Literature DB >> 9630359

Ovalbumin-induced neurogenic inflammation in the bladder of sensitized rats.

A Ahluwalia1, S Giuliani, R Scotland, C A Maggi.   

Abstract

1. We have developed and characterized a model of immediate hypersensitivity/inflammation of the urinary bladder in vivo induced by local application of ovalbumin (OA) in OA- sensitive female rats. Two parameters of the inflammatory response were assessed following OA challenge: plasma protein extravasation (PPE) and changes in smooth muscle reactivity. The former was estimated by measurement of Evans blue extravasation at 0.5, 2, 4, 8 and 24 h time point following in vivo challenge. Changes in reactivity were determined by measurement of isotonic tension responses of urinary bladder strips following OA challenge in vitro. 2. Acute in vivo intravesical OA challenge (10 mg in 0.3 ml saline) in actively sensitized female Wistar rats caused a time-dependent PPE in the urinary bladder which was biphasic with peak responses at 2-4 and 24 h. 3. The PPE response to acute OA challenge, above base-line, at 2 h was abolished by systemic capsaicin pretreatment (50 mg kg(-1), s.c., 4 days before use) (P < 0.05) whilst the response at 24 h was unaffected. The 2 h time point was then used for further studies. 4. Degranulation of mast cells, achieved by pretreatment with compound 48/80 (5 mg kg(-1), s.c. for 3 consecutive days), completely abolished the PPE response to OA challenge at the 2 h time point. 5. The tachykinin NK1 receptor antagonist, SR 140333 (0.1 micromol kg(-1), i.v.), abolished the 2 h PPE response whilst the tachykinin NK2 receptor antagonist MEN 11420 (0.1 micromol kg(-1), i.v.) appeared to reduce the response by approximately 50% but this did not reach significance. The bradykinin B2 receptor antagonist, Hoe 140 (0.1 micromol kg(-1), i.v.), similarly to SR 140333, blocked the 2 h PPE response to OA, whereas the selective B1 receptor antagonist B 9858 (0.1 micromol kg(-1), i.v.) had no significant effect. Inhibition of cyclo-oxygenase (COX) achieved by pretreatment with the COX inhibitor dexketoprofen (5.3 micromol kg(-1), i.v.) also blocked the PPE response, whilst the leukotriene receptor antagonist ONO 1078 (1 micromol kg(-1), i.v.) significantly reduced PPE by about 80%. 6. In the rat isolated urinary bladder OA (1 mg ml(-1)) challenge produced a biphasic response with a rapidly achieved maximal contraction followed by a sustained contraction for approximately 25 min. In vitro capsaicin pretreatment (10 microM for 15 min) significantly attenuated the duration of the sustained contraction whilst having no effect on the maximum contractile response achieved. In vivo pretreatment of animals with compound 48/80 significantly attenuated (42%) the maximum contractile response. Combination of both treatments almost completely abolished the response. In vitro treatment with Hoe 140 (1 microM) had no significant effect on the response to OA and neither did ONO 1078 (1 microM). 7. These results show that both the early inflammatory response and alterations in smooth muscle reactivity to OA challenge in actively sensitized animals are dependent on mast cell degranulation and the activation of sensory C-fibres. Furthermore this model of allergic cystitis may be useful for investigating both the processes involved and potential novel therapies in the treatment of interstitial cystitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630359      PMCID: PMC1565355          DOI: 10.1038/sj.bjp.0701793

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity.

Authors:  Dan Levy; Vanessa Kainz; Rami Burstein; Andrew M Strassman
Journal:  Brain Behav Immun       Date:  2011-10-12       Impact factor: 7.217

2.  Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats.

Authors:  C Bandeira-Melo; A S Calheiros; P M Silva; R S Cordeiro; M M Teixeira; M A Martins
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  The plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive primary afferent neurones and mast cells.

Authors:  L C Esquisatto; S K Costa; E A Camargo; M T Ribela; S D Brain; G de Nucci; E Antunes
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 4.  Neuropeptides in lower urinary tract function.

Authors:  Lauren Arms; Margaret A Vizzard
Journal:  Handb Exp Pharmacol       Date:  2011

5.  Effect of anti-siglec-f antibody and reactive oxygen species blocking on histamine release in urinary bladder of ovalbumin-treated mice.

Authors:  Bo-Hwa Choi; Gwoan-Youb Choo; Ju-Hee Kang; Choong-Yeol Lee; Chang-Shin Park
Journal:  Int Neurourol J       Date:  2012-09-30       Impact factor: 2.835

Review 6.  Role of neurogenic inflammation in local communication in the visceral mucosa.

Authors:  Lori A Birder; F Aura Kullmann
Journal:  Semin Immunopathol       Date:  2018-03-26       Impact factor: 9.623

Review 7.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

8.  Evidence for the role of mast cells in colon-bladder cross organ sensitization.

Authors:  Jocelyn J Fitzgerald; Elena Ustinova; Kevin B Koronowski; William C de Groat; Michael A Pezzone
Journal:  Auton Neurosci       Date:  2012-11-24       Impact factor: 3.145

Review 9.  Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist's Perspective.

Authors:  Tae Young Jang; Young Hyo Kim
Journal:  Int Neurourol J       Date:  2015-09-22       Impact factor: 2.835

10.  Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord.

Authors:  Peter Zvara; Margaret A Vizzard
Journal:  BMC Physiol       Date:  2007-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.